Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we inves...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae862c9def61413fb56c973f7d4c3627 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ae862c9def61413fb56c973f7d4c3627 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ae862c9def61413fb56c973f7d4c36272021-11-14T12:06:41ZKnockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells10.1038/s41419-021-04347-72041-4889https://doaj.org/article/ae862c9def61413fb56c973f7d4c36272021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04347-7https://doaj.org/toc/2041-4889Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we investigated the expression and function of UBA2 in ccRCC. Both mRNA and protein expression levels of UBA2 were found to be higher in ccRCC than in normal renal tissues and significantly related to the tumor size, Fuhrman grade, and tumor stage. UBA2 knockdown inhibited ccRCC cell growth, promoted apoptosis in vitro and in vivo, and decreased the abundance of a p53 mutant, c-Myc, and key enzymes of the SUMO modification system. Meanwhile, overexpression of UBA2 had the opposite effects. Overexpression of the p53 mutant or c-Myc alleviated the effects of UBA2 knockdown on ccRCC cell proliferation and apoptosis. In conclusion, targeting UBA2 may have a therapeutic potential against ccRCC.Guoxi ZhangJunrong ZouJinglin ShiBiao QianKaiyang QiuQuanliang LiuTianpeng XieZhihua HeHui XuYunfeng LiaoYuting WuYanmin LiGuancheng XiaoYuanhu YuanRihai XiaoGengqing WuXiaofeng ZouNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 11, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Cytology QH573-671 |
spellingShingle |
Cytology QH573-671 Guoxi Zhang Junrong Zou Jinglin Shi Biao Qian Kaiyang Qiu Quanliang Liu Tianpeng Xie Zhihua He Hui Xu Yunfeng Liao Yuting Wu Yanmin Li Guancheng Xiao Yuanhu Yuan Rihai Xiao Gengqing Wu Xiaofeng Zou Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
description |
Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we investigated the expression and function of UBA2 in ccRCC. Both mRNA and protein expression levels of UBA2 were found to be higher in ccRCC than in normal renal tissues and significantly related to the tumor size, Fuhrman grade, and tumor stage. UBA2 knockdown inhibited ccRCC cell growth, promoted apoptosis in vitro and in vivo, and decreased the abundance of a p53 mutant, c-Myc, and key enzymes of the SUMO modification system. Meanwhile, overexpression of UBA2 had the opposite effects. Overexpression of the p53 mutant or c-Myc alleviated the effects of UBA2 knockdown on ccRCC cell proliferation and apoptosis. In conclusion, targeting UBA2 may have a therapeutic potential against ccRCC. |
format |
article |
author |
Guoxi Zhang Junrong Zou Jinglin Shi Biao Qian Kaiyang Qiu Quanliang Liu Tianpeng Xie Zhihua He Hui Xu Yunfeng Liao Yuting Wu Yanmin Li Guancheng Xiao Yuanhu Yuan Rihai Xiao Gengqing Wu Xiaofeng Zou |
author_facet |
Guoxi Zhang Junrong Zou Jinglin Shi Biao Qian Kaiyang Qiu Quanliang Liu Tianpeng Xie Zhihua He Hui Xu Yunfeng Liao Yuting Wu Yanmin Li Guancheng Xiao Yuanhu Yuan Rihai Xiao Gengqing Wu Xiaofeng Zou |
author_sort |
Guoxi Zhang |
title |
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
title_short |
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
title_full |
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
title_fullStr |
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
title_full_unstemmed |
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
title_sort |
knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells |
publisher |
Nature Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/ae862c9def61413fb56c973f7d4c3627 |
work_keys_str_mv |
AT guoxizhang knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT junrongzou knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT jinglinshi knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT biaoqian knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT kaiyangqiu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT quanliangliu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT tianpengxie knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT zhihuahe knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT huixu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT yunfengliao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT yutingwu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT yanminli knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT guanchengxiao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT yuanhuyuan knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT rihaixiao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT gengqingwu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells AT xiaofengzou knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells |
_version_ |
1718429482675601408 |